Semantic Scholar uses AI to extract papers important to this topic.
Development of an intravenous formulation of SU010382 (prodrug of SU5416, an anti-angiogenesis agent).
- PDA journal of pharmaceutical science and…
SU5416, the first in a new class of anti-angiogenesis agents, is an insoluble and neutral molecule which requires a formulation… Expand
Is this relevant?